A randomized Phase 2 study comparing different dosing approaches of induction treatment (first cycle) of regorafenib in metastatic colorectal cancer (mCRC) patients

Autor:	P. García-Alfonso, Fortunato Ciardiello, Maria Tobeña, M. Rodríguez-Garrote, F. Rivera Herrero, G. Argiles Martinez, M.J. Safont, Jaafar Bennouna, Carlos Ferreira dos Santos, Cristina Grávalos, Manuel Valladares-Ayerbes, A. Falcone, Enrique Sanz-Garcia, E. Aranda Aguilar, Beatriz García-Paredes, Jose María Vieitez, Richard M. Goldberg, J. Tabernero, G. Duran Ogaya, M.T. Cano Osuna
Rok vydání:	2017
Předmět:	Oncology medicine.medical_specialty business.industry Colorectal cancer Phases of clinical research Hematology medicine.disease chemistry.chemical_compound chemistry Regorafenib Internal medicine medicine Dosing business INDUCTION TREATMENT
Zdroj:	Annals of Oncology. 28:v206-v207
ISSN:	0923-7534
DOI:	10.1093/annonc/mdx393.135
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::568ad90153ad786a7d47f5a22e629550 https://doi.org/10.1093/annonc/mdx393.135 Zobrazit plný text záznamu